Related Experiment Video
Updated: Dec 31, 2025

07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.3K
Schwann cell reprogramming and lung cancer progression: a meta-analysis of transcriptome data
Victor Menezes Silva1, Jessica Alves Gomes1, Liliane Patrícia Gonçalves Tenório1
1Department of Medicine, Federal University of Alagoas, Campus Arapiraca, Brazil.
Oncotarget
|January 11, 2020
Summary
Schwann cells promote lung cancer invasion via direct contact. This study identifies key biomolecules and microRNAs involved in Schwann cell dedifferentiation and migration, offering potential biomarkers for lung adenocarcinoma and lung squamous cell carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Schwann cells are implicated in the initial stages of tumor invasion.
- Direct cell-cell contact, rather than signaling or matrix remodeling, appears crucial for cancer cell invasion mediated by Schwann cells.
- Understanding the molecular mechanisms underlying Schwann cell involvement in cancer progression is essential.
Purpose of the Study:
- To investigate the role of Schwann cells in lung cancer invasion using a systems biology approach.
- To identify key genes, pathways, and microRNAs associated with Schwann cell dedifferentiation and their impact on lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC).
- To evaluate the potential of identified biomolecules as diagnostic or therapeutic targets for perineural invasion in lung cancer.
Main Methods:
- Genome-scale biomolecular network analysis.
- Meta-analysis of Schwann cell-associated transcriptomic datasets.
- Statistical analysis of differentially expressed genes (DEGs).
- Gene set over-representation and pathway enrichment analyses.
- Transcriptional and post-transcriptional regulatory network reconstruction for microRNAs.
- Microarray-based transcriptome profiling and prognostic prediction.
Main Results:
- Schwann cell dedifferentiation pathways were found to be overexpressed in lung cancer samples.
- Genes involved in Schwann cell migration inhibition were downregulated in lung cancer.
- Dysregulation of microRNAs targeting these pathways was observed.
- Identified biomolecules showed prognostic potential.
Conclusions:
- Schwann cell dedifferentiation and altered migration pathways are significant in lung cancer.
- Deregulation of specific microRNAs contributes to the observed molecular changes.
- The identified Schwann cell-derived biomolecules hold promise as novel biomarkers for lung cancer screening and therapy, particularly in cases of perineural invasion.
